Contact this trialFirst, we need to learn more about you.
Cancer Vaccine + Entinostat + Nivolumab for Esophageal Cancer
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial evaluates safety and immune response of a vaccine to treat locally advanced esophageal cancer. Phase I will determine safe dose, and Phase II will assess level of immune response.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.